Evolving concepts in cell therapy of liver disease and current clinical perspectives

Digestive and Liver Disease

Volumn 43, Issue 3, 2011, Pages 180-187

  Muraca, Maurizio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Liver cell therapy; Liver stem cells

Indexed keywords

CD133 ANTIGEN; DNA; INTEGRIN; MITOCHONDRIAL DNA;

BONE MARROW CELL; CD34 SELECTION; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CELL THERAPY; DIPLOIDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GENE MUTATION; HEMATOPOIETIC STEM CELL; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER CELL; LIVER DISEASE; LIVER TUMOR; MESENCHYMAL STEM CELL; NONHUMAN; PLASTICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEM CELL; STEM CELL NICHE;

BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 79551482651     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.08.007     Document Type: Review

References (95)

1. Fisher R.A., Strom S.C. Human hepatocyte transplantation: worldwide results. Transplantation 2006, 82:441.
2. Michalopoulos G.K. Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 2009, [Epub ahead of print].
3. Overturf K., al-Dhalimy M., Ou, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997, 151:1273-1280.
4. Hytiroglou P., Theise N.D. Telomerase activation in human hepatocarcinogenesis. Am J Gastroenterol 2006, 101:839-841.
5. Morrison S.J., Spradling A.C. Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 2008, 132:598-611.
6. Gaudio E., Carpino G., Cardinale V., et al. New insights into liver stem cells. Dig Liver Dis 2009, 41:455-462.
7. Alison M.R., Brittan M., Lovell M.J., et al. Markers of adult tissue-based stem cells. Handb Exp Pharmacol 2006, 174:185-227. [Review].
8. Kuwahara R., Kofman A.V., Landis C.S., et al. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology 2008, 47:1994-2002.
9. Zhang L., Theise N., Chua M., et al. The stem cell niche of human livers: symmetry between development and regeneration. Hepatology 2008, 48:1598-1607.
10. Fellous T.G., Islam S., Tadrous P.J., et al. Locating the stem cell niche and tracing hepatocyte lineages in human liver. Hepatology 2009, 49:1655-1663.
11. Lorenzini S., Bird T.G., Boulter L., et al. Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut 2010, 59:645-654.
12. Glaser S.S., Onori P., Wise C., et al. Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasis. Dig Liver Dis 2010, 42:245-252.
13. Glaser S.S., Gaudio E., Miller T., et al. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med 2009, 11:e7.
14. Petersen B.E., Bowen W.C., Patrene K.D., et al. Bone marrow as potential source of hepatic oval cells. Science 1999, 284:1168-1170.
15. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000, 406:257.
16. Lagasse E., Connors H., Al-Dhalimy M., et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000, 6:1229-1234.
17. Theise N.D., Badve S., Saxena R., et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000, 31:235-240.
18. Schwartz R.E., Reyes M., Koodie L., et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002, 109:1291-1302.
19. Kucia M., Ratajczak J., Ratajczak M.Z. Are bone marrow stem cells plastic or heterogenous-that is the question. Exp Hematol 2005, 33:613-623.
20. Theise N.D., Harris R. Postmodern biology: (adult) (stem) cells are plastic, stochastic, complex, and uncertain. Handb Exp Pharmacol 2006, 174:389-408. [Review].
21. Wang X., Willenbring H., Akkari, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003, 422:897-901.
22. Terada R., Yamamoto K., Hakoda T., et al. Stromal cell-derived factor-1 from biliary epithelial cells recruits CXCR4-positive cells: implications for inflammatory liver diseases. Lab Invest 2003, 83:665-672.
23. Forbes S.J. Myelomonocytic cells are sufficient for therapeutic cell fusion in the liver. J Hepatol 2005, 42:285-286.
24. Thorgeirsson S.S., Grisham J.W. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology 2006, 43:2-8.
25. Graf T., Enver T. Forcing cells to change lineages. Nature 2009, 462:587-594.
26. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009, 460:49-52.
27. Jang Y.Y., Collector M.I., Baylin S.B., et al. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004, 6:532-539.
28. Muraca M., Ferraresso C., Vilei M.T., et al. Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat. Gut 2007, 56:1725-1735.
29. Aliotta J.M., Sanchez-Guijo F.M., Dooner G.J., et al. Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 2007, 25:2245-2256.
30. Oh S.H., Witek R.P., Bae S.H., et al. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology 2007, 132:1077-1087.
31. Colvin G.A., Lambert J.F., Abedi M., et al. Differentiation hotspots: the deterioration of hierarchy and stochasm. Blood Cells Mol Dis 2004, 32:34-41.
32. Sancho-Bru P., Najimi M., Caruso M., et al. Stem and progenitor cells for liver repopulation: can we standardize the process from bench to bedside?. Gut 2009, 58:594-603.
33. Kakinuma S., Tanaka Y., Chinzei R., et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003, 21:217-227.
34. Kögler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200:123-135.
35. De Coppi P., Bartsch G., Siddiqui M.M., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106. [Jan Epub 2007 Jan 7].
36. Miki T., Marongiu F., Ellis E.C., et al. Production of hepatocyte-like cells from human amnion. Methods Mol Biol 2009, 481:155-168.
37. Ghionzoli M., Cananzi M., Zani A., et al. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int 2009.
38. Sharma A.D., Cantz T., Vogel A., et al. Murine embryonic stem cell derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation. Cell Transplant 2008, 17:313-323.
39. Basma H., Soto-Gutiérrez A., Yannam G.R., et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136:990-999.
40. Gupta S., Rajvanshi P., Sokhi R., et al. Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 1999, 29:509-519.
41. Grompe M., Laconi E., Shafritz D.A. Principles of therapeutic liver repopulation. Semin Liver Dis 1999, 19:7.
42. Gupta S., Inada M., Joseph B., et al. Emerging insights into liver-directed cell therapy for genetic and acquired disorders. Transpl Immunol 2004, 12:289-302.
43. Oren R., Dabeva M.D., Petkov P.M., et al. Restoration of serum albumin levels in Nagase analbuminemic rats by hepatocyte transplantation. Hepatology 1999, 29:75-81.
44. Herrera M.B., Bruno S., Buttiglieri S., et al. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006, 24:2840-2850.
45. Najimi M., Khuu N.D., Lysy P., et al. Adult derived human liver mesenchymal-like cells as a potential progenitors reservoir of hepatocytes?. Cell Transpl 2007, 16:717-728.
46. Gehling U.M., Willems M., Dandri M., et al. Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol 2005, 43:845-853.
47. Sandhu J., Petkov P.M., Dabeva M.D., et al. Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol 2001, 159:1323-1334.
48. Oertel M., Menthena A., Dabeva M.D., et al. Cell competition leads to a high level of normal liver reconstitution by transplanted fetal liver stem/progenitor cells. Gastroenterology 2006, 130:507-520.
49. Muraca M., Gerunda G., Neri D., et al. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002, 359:1528.
50. Kumaran V., Joseph B., Benten D., et al. Integrin and extracellular matrix interactions regulate engraftment of transplanted hepatocytes in the rat liver. Gastroenterology 2005, 129:1643-1653.
51. Krause D.S., Theise N.D., Collector M.I., et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001, 105:369-377.
52. Aiuti A., Webb I.J., Bleul C., et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111-120.
53. Dalakas E., Newsome P.N., Harrison D.J., et al. Hematopoietic stem cell trafficking in liver injury. FASEB J 2005, 19:1225-1231.
54. Kollet O., Petit I., Kahn J., et al. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation. Blood 2002, 100:2778-2786.
55. Nagasawa T., Tachibana K., Kawabata K. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Adv Immunol 1999, 71:211-228.
56. Kollet O., Shivtiel S., Chen Y.Q., et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003, 112:160-169.
57. Hatch H.M., Zheng D. Jorgensen ML, and Petersen BE. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002, 4:339-351.
58. Swenson E.S., Kuwahara R., Krause D.S., et al. Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration. Liver Int 2008, 28:308-318.
59. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637.
60. Weimar I.S., Miranda N., Muller E.J., et al. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+). Exp Hematol 1998, 26:885-894.
61. Armbrust T., Batusic D., Xia L., et al. Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride. Liver 2002, 22:486-494.
62. Peled A., Petit I., Kollet O., Magid M., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
63. Strom S.C., Chowdhury J.R., Fox I.J. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999, 39-48.
64. Matas A.J., Sutherland D.E.R., Steffes M.W., et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science 1976, 192:892-894.
65. Demetriou A.A., Whiting J.F., Feldman D., et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science 1986, 233:1190-1192.
66. Overturf K., Al-Dhalimy M., Tanguay R., et al. Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary throsinemia type 1. Nat Genet 1996, 12:266-273.
67. Yoshida Y., Tokusashi Y., Lee G.H., et al. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 1996, 111:1654-1660.
68. De Vree J.M., Ottenhoff R., Bosma P.J., et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000, 119:1720-1730.
69. Michel J.L., Rabier D., Rambaud C., et al. Intrasplenic transplantation of hepatocytes in spf ash mice with congenital ornithine transcarbamylase deficiency. Chirurgie 1993, 119:666-671.
70. Wiederkehr J.C.K.G., Pollak R. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit. Transplantation 1990, 50:466-471.
71. Kocken J.M., Borel Rinkes I.H., Bijma A.M., et al. Correction of an inborn error of metabolism by intraportal hepatocyte transplantation in a dog model. Transplantation 1996, 62:358-364.
72. Fox I.J., Chowdhury J.R., Kaufman S.S., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998, 338:1422-1426.
73. Horslen S.P., McCowan T.C., Goertzen T.C., et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003, 111:1262-1267.
74. Stéphenne X., Najimi M., Sibille C., et al. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 2006, 130:1317-1323.
75. Dhawan A., Mitry R.R., Hughes R.D., et al. Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 2004, 78:1812-1814.
76. Grossman M., Rader D.J., Muller D.W., et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995, 1:1148-1154.
77. Demetriou A.A., Brown R.S., Busuttil R.W., et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004, 239:660.
78. Ellis A.J., Hughes R.D., Wendon J.A., et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996, 24:1446-1451.
79. Kjaergard L.L., Liu J., Als-Nielsen B., et al. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. J Am Med Assoc 2003, 289:217.
80. Habibullah C.M., Syed I.H., Qamar A., et al. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994, 58:951-952.
81. Strom S.C., Fisher R.A., Thompson M.T., et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997, 63:559-569.
82. Bilir B.M., Guinette D., Karrer F., et al. Hepatocyte transplantation in acute liver failure. Liver Transpl 2000, 6:32-40.
83. Stéphenne X., Najimi M., Janssen M., et al. Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety. Liver Int 2005, 25:1108-1113.
84. Stéphenne X., Najimi M., Ngoc D.K., et al. Criopreservation of human hepatocytes alters the mitochondrial respiratory chain complex I. Cell Transpl 2007, 16:409-419.
85. David P., Alexandre E., Auder M., et al. Engrafment and albumin production of intrasplenically transplanted rat hepatocytes (Spragwe-Dawley), freshly isolated versus cryopreserved into Nagase analbunimemic rats (NAR). Cell Transpl 2001, 10:67-80.
86. Terry C., Dhawan A., Mitry R., et al. Cryopreservation of isolated human hepatocytes for transplantation: state of the art. Cryobiology 2006, 53:149-159.
87. Galbiati G., Muraca M., Mitry R.R., et al. Bilirubin can improve cryopreservation of human hepatocytes. J Pediatr Gastroenterol Nutr. 2010, 50:691-693.
88. Evans H.M., Kelly D.A., Mckiernan P.J., et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006, 43:1109-1117.
89. Idilman R., Erden E., Kuzu I., et al. Recipient-derived hepatocytes in sex-mismatched liver allografts after liver transplantation: early versus late transplant biopsies. Transplantation 2004, 78:1647-1652.
90. Gasbarrini A., Rapaccini G.L., Rutella S., et al. Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis 2006, 39:878-882. [2007 Sep Epub].
91. Gordon M.Y., Levicar N., Pai M., et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006, 24:1822-1830.
92. Pai M., Zacharoulis D., Milicevic M.N., et al. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008, 103:1952-1958.
93. Yannaki E., Athanasiou E., Xagorari A., et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol 2005, 33:108-119.
94. Am Esch J.S., Tustas R.Y., Robson S.C., et al. Recipient levels and function of von Willebrand factor prior to liver transplantation and its consumption in the course of grafting correlate with hepatocellular damage and outcome. Transpl Int 2005, 18:1258-1265.
95. Houlihan D.D., Newsome P.N. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology. 2008, 135:438-450.